If you have started reading about treatments for vaginal dryness or recurrent urinary symptoms, you have probably run into two phrases that sound similar but mean very different things: systemic hormone therapy and local vaginal estrogen. Understanding the difference is the key to understanding why local estrogen is so widely recommended for genitourinary symptoms.
What 'local' actually means
The tissues of the vulva, vagina, urethra, and bladder are rich in estrogen receptors. They depend on estrogen to stay thick, elastic, well lubricated, and well supplied with blood. When estrogen declines during perimenopause and menopause, these tissues gradually thin and lose moisture, and the vaginal environment becomes less acidic. The same low-estrogen changes can also occur temporarily during breastfeeding, when the hormones that support milk production suppress estrogen. That related condition is now called genitourinary syndrome of lactation (GSL), and we will cover it in another blog post. This cluster of changes around menopause is what clinicians call genitourinary syndrome of menopause, or GSM.
Local vaginal estrogen is applied directly to the area that needs it. It works by restoring estrogen to those receptor-rich tissues, which helps rebuild the vaginal lining, improve blood flow, and lower vaginal pH back toward its premenopausal range. It also helps keep the vaginal microbiome balanced by supporting beneficial lactobacilli, the 'good' bacteria a healthy vagina depends on. These lactobacilli produce lactic acid, which keeps the vaginal environment slightly acidic and discourages the overgrowth of the organisms that cause infection and irritation.
Why 'minimal absorption' matters
The most important distinction is dose. Systemic therapy, such as estrogen pills and patches, is designed to circulate throughout the body and treat whole-body symptoms like hot flashes and night sweats. Local vaginal estrogen uses a far smaller dose that mostly stays where it is applied.
The absorption numbers are striking. According to The Menopause Society's 2020 GSM position statement, blood estradiol levels after two weeks of daily use of the 10 mcg vaginal insert measured around 4.6 pg/mL, which was not statistically different from the level in women using a placebo, that is, no active treatment at all, at about 4.3 pg/mL. To put that figure in context, estradiol is measured in picograms per milliliter (pg/mL). Before menopause, a woman's estradiol typically ranges from roughly 15 to 350 pg/mL across the monthly cycle, and after menopause it usually sits below about 10 to 30 pg/mL. A reading of 4.6 pg/mL is at the very low end of that spectrum, which is another way of saying that very little of the hormone reaches the bloodstream.
How this guides treatment
Because local estrogen targets the genitourinary tissues specifically, it is often the preferred option for women whose main concerns are dryness, painful sex, or urinary symptoms, including many women who do not want or cannot take systemic hormones. At Antha, we offer two local estradiol options: estradiol vaginal cream 0.01% and estradiol vaginal tablet inserts 10 mcg. Both deliver estradiol directly to the tissues that need it.
If your symptoms are mostly below the belt, local vaginal estrogen is worth understanding and discussing with a clinician.
Related reading
Sources
This article is for educational purposes and is not a substitute for personalized medical advice.